Project Grant HT94252310351
Award Date 6/15/23
Completion Date 6/14/27
Dollars Obligated $1.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21250, USA
Similar Awards
- The University of Maryland, Baltimore (UMB) was awarded a $587,271 Project Grant from the Defense Health Agency, under the Department of Defense's Military Medical Research and Development program (CFDA 12.420), to conduct research on "DUAL INHIBITION OF PARP AND IL-6 AS A NOVEL THERAPEUTIC APPROACH FOR BRCA-MUTATED TRIPLE-NEGATIVE BREAST CANCER." This research project will occur from July 1, 2024 to June 30, 2027. The Military Medical Research and Development program supports a...
- The Defense Health Agency awarded Rutgers, The State University of New Jersey a $942,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support targeted chemotherapeutic and immunotherapeutic research for drug-resistant ovarian cancer. The three-year award beginning April 1, 2023 will fund Rutgers Biomedical and Health Sciences' investigation into medical solutions for this treatment-resistant form of ovarian cancer through innovative research...
- The University of Maryland, Baltimore was awarded a $1.15 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research on BPTF-Mediated Gene Regulation in Prostate Cancer from August 1, 2022 to July 31, 2025. As part of the Military Medical Research and Development program's goal of transforming health care for service members and the public through innovative biomedical research, this project aims...
- The University of Maryland, Baltimore was awarded a two-year, $154,500 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund research into regulating the activity of poly (ADP-ribose) polymerase or PARP enzyme through ubiquitin E3 ligase RNF6 in prostate cancer. As part of the Military Medical Research and Development program's goal of transforming military and public health through innovative medical research, this...
- The University of British Columbia (UBC) received a $507,035 Project Grant award from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420). The grant, awarded on September 1, 2023, will fund research for "The Ovarian Cancer Observatory: Prevention, Impact, and Learning from Opportunistic Salpingectomy" over a 4-year period through August 31, 2027. As the prime grantee, UBC will leverage its expertise in medical research and data analysis...
- This federal Project Grant award of $400,000.00 was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, with a performance period from October 1, 2024 to September 30, 2026. The award supports research by the University of Maryland, Baltimore to develop "drug conjugates of modified LGR4/5/6 ligands for cancer treatment." The university, as the prime awardee, has extensive expertise in biomedical research, clinical trials, and...
- The University of Pittsburgh was awarded a $954,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from May 2023 to May 2026 aimed at epigenetic reprogramming to target senescent ovarian cancer cells and overcome therapeutic resistance. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
- The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $467,742 Project Grant to the Regents of the University of Michigan to optimize a risk stratification model for ovarian cancer. The award will support research activities from September 1, 2024 through August 31, 2026. The University of Michigan, a top public research institution, has extensive experience conducting federal research and development projects for agencies such as the...
- The Defense Health Agency awarded a $1,204,746 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Old Dominion University Research Foundation (Odurf) for the project "Early Detection of Cancer Disparity and Treatment Resistance in TNBC". The grant, with a performance period from September 1, 2024 to January 31, 2027, will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the...
- The University of Michigan will receive $782,729 from the Department of the Army Medical Command under a Project Grant award through the Military Medical Research and Development program (CFDA 12.420) to improve outcomes for women with ovarian cancer. The four-year award beginning September 1, 2022 will support research to transform healthcare for Service Members and the public through innovative medical solutions for the battlefield and investigation of solutions for ovarian cancer. The...